StockWatch
·
Medicinal Chemicals & Botanical Products
Quarterly ResultMay 12, 2026, 04:32 PM

Jushi Q1 Revenue $66.4M, Operating Income $1.6M; Net Loss $(19.8)M

AI Summary

Jushi Holdings Inc. reported Q1 2026 net revenue of $66.4 million, a 4.05% increase year-over-year, and achieved operating income of $1.6 million, a significant improvement from an operating loss of $(1.9) million in Q1 2025. Despite operational gains, the company's net loss widened to $(19.8) million, up from $(17.0) million in the prior year, partly due to a $5.0 million loss on debt extinguishment. Jushi also refinanced its 2024 Term Loan and Second Lien Notes with a new $160.0 million 2026 Term Loan.

Key Highlights

  • Net revenue increased 4.05% to $66.4 million for Q1 2026 from $63.8 million in Q1 2025.
  • Gross profit rose 15.9% to $29.9 million in Q1 2026, compared to $25.8 million in Q1 2025.
  • Operating income reached $1.6 million in Q1 2026, a significant improvement from a $(1.9) million operating loss.
  • Net loss for Q1 2026 widened to $(19.8) million, up from $(17.0) million in Q1 2025.
  • Loss per share was $(0.10) for Q1 2026, compared to $(0.09) in Q1 2025.
  • Refinanced debt with a new $160.0 million 2026 Term Loan, maturing March 2029.
  • Reported a $5.0 million loss on debt extinguishment/modification in Q1 2026.
  • Net cash provided by operating activities increased to $8.6 million from $7.5 million.